The following table contains a summary of product launches and approvals identified in international markets in recent weeks.
|Generic name||Trade name (Company)||Indication/category||Country|
|Balsalazide (L)||Colazal (Salix Pharmaceuticals)||Treatment of ulcerative colitis||US|
|Caspofungin (A)||Cancidas (Merck & Co.)||Treatment of invasive aspergillosis||US|
|Crotalid antivenin (L)||CroFab (Protherics)||Treatment of snake bites||US|
|Linezolid (A)||Zyvox (Pharmacia Corporation)||Treatment of Gram-positive infections||UK|
|Pneumococcal conjugate vaccine (A)||Prevenar (Wyeth-Lederle Vaccines)||Prevention of invasive pneumococcal disease||EU|
|Ziprasidone (A)||NA (Pfizer)||Treatment of schizophrenia||US|
A = approved; L = launched; EU = European Union; NA = not available.
© 2001 Adis Data Information BV
Cite this: New in the Marketplace - Medscape - Mar 12, 2001.